Qantas Airways share price on watch as FY26 profit dips but dividend and upgrades unveiled

The airline reported profit dip but declared a 19.8c dividend.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Qantas Airways Ltd (ASX: QAN) share price is in focus today after the company posted a statutory profit after tax of $1.29 billion and declared a final fully franked dividend of 19.8 cents per share for FY26.

Happy couple looking at a phone and waiting for their flight at an airport.

Image source: Getty Images

What did Qantas Airways report?

  • Underlying Profit Before Tax: $2.06 billion, down $330 million from FY25
  • Statutory Profit After Tax: $1.29 billion, down $316 million
  • Final dividend: 19.8 cents per share (fully franked), total FY26 dividends $600 million
  • Underlying earnings per share: 96 cents, down 14 cents
  • Net capital expenditure: $4.0 billion, up 3%
  • 17 new aircraft delivered during the year

What else do investors need to know?

Qantas continued to invest heavily in new aircraft and training facilities, marking the largest fleet renewal in its history. The group opened a new training centre in Mascot as part of a $100 million upgrade.

Around 25,000 eligible non-executive employees will each receive $1,000 in Qantas shares, following another year of meeting financial targets. Qantas Loyalty delivered strong results, with a 12% increase in underlying EBIT and record engagement from frequent flyers.

Net debt increased to $6.2 billion, remaining within management's target range. The Board cancelled a planned $150 million share buy-back as part of its capital management.

What did Qantas Airways management say?

Commenting on the results, Qantas' CEO, Vanessa Hudson, said:

This has been another year of progress, with customer satisfaction at its highest in a decade and world-leading operational performance, even as the aviation industry faced record high fuel costs and disruption from the conflict in the Middle East. We came through it with a strong result, which is what allows us to continue investing in the largest fleet renewal in our history and deliver more for our customers, people and shareholders.

What's next for Qantas Airways?

Qantas expects domestic and international travel demand to remain resilient, with capacity growth and new routes on the horizon in FY27. The group will receive its first Project Sunrise A350-1000ULR in April, and the first non-stop Sydney-London flight will launch in October.

Management forecasts unit revenues to grow by 8–10% in the first half of FY27, despite ongoing pressure from elevated fuel prices. Qantas Loyalty earnings are expected to increase by 5–7% next year, and investment in new aircraft and employee training will continue.

Qantas Airways share price snapshot

Over the past 12 months, the Qantas Airways share price has underperformed the S&P/ASX 200 index (ASX: XJO) with a decline of almost 20%.

View Original Announcement

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

More on Earnings Results

Happy shareholders clap and smile as they listen to a company earnings report.
Industrials Shares

Tasmea posts strong FY26 earnings, upgrades FY27 guidance

Tasmea's FY26 results exceeded guidance with strong earnings growth and upgraded its FY27 outlook.

Read more »

Three smiling corporate people examine a model of a new building complex.
Earnings Results

Cromwell Property Group lifts FFO and expands assets under management in FY26

The company has announced portfolio progress and outlined plans for further expansion.

Read more »

Oil worker using a smartphone in front of an oil rig.
Earnings Results

Karoon Energy half-year earnings: FY26 results and outlook

Let's see what the energy producer reported for the first half.

Read more »

Two workers on a tablet at a mine site, with mining machinery behind them.
Earnings Results

Emerald Resources FY26 earnings: Record profit on gold price surge

The miner's results show record profit, strong gold production, and healthy growth across Australia and Cambodia.

Read more »

Female pharmacist smiles with a digital tablet.
Earnings Results

Sigma Healthcare FY26 earnings: Record profit as Chemist Warehouse merger delivers growth

The company reported double-digit revenue growth.

Read more »

A woman sits miserable behind the wheel of her car.
Earnings Results

Bapcor Ltd FY26 earnings: turnaround gains, big impairment loss

Its shares are under the microscope after a turnaround year delivered stronger cash flow but a large non-cash impairment.

Read more »

Businessman at his desk, looking seriously at information on his digital tablet.
Earnings Results

Perpetual posts higher FY26 profit and readies for business sale

Perpetual’s FY26 result shows rising profit, ongoing cost cuts and a major business sale due to complete later in 2026.

Read more »

Health professional working on his laptop.
Earnings Results

Mesoblast earnings: Strong revenue growth and operational milestones in FY26

The biotech has reported a significant jump in revenue.

Read more »